Search research articles
Contact Us
Filters
Showing results (121-130 of 131) with videos related to
Page
of 14
Sort By:
Oncoimmunology
|
August 15, 2025
A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages
Katherine M Bever, Sarah M Shin, Jennifer N Durham, et al.
Cell Metabolism
|
November 19, 2019
Selective Persulfide Detection Reveals Evolutionarily Conserved Antiaging Effects of S-Sulfhydration
Jasmina Zivanovic, Emilia Kouroussis, Joshua B Kohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer
Thatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
Biorxiv : the Preprint Server for Biology
|
October 31, 2023
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade
Daniel H Shu, Won Jin Ho, Luciane T Kagohara, et al.
Iscience
|
January 15, 2025
CD137 agonism enhances anti-PD1 induced activation of expanded CD8<sup>+</sup> T cell clones in a neoadjuvant pancreatic cancer clinical trial
Janelle M Montagne, Jacob T Mitchell, Joseph A Tandurella, et al.
Nature Communications
|
February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial
Amanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Nature Communications
|
April 15, 2026
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial
Amanda L Huff, S Daniel Haldar, Alexander A Girgis, et al.
The Journal of Trauma and Acute Care Surgery
|
April 4, 2023
Moving the needle on time to resuscitation: An EAST prospective multicenter study of vascular access in hypotensive injured patients using trauma video review
Ryan P Dumas, Michael A Vella, Amelia W Maiga, et al.
Nature Immunology
|
October 25, 2024
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma
Daniel H Shu, Won Jin Ho, Luciane T Kagohara, et al.
The Journal of Clinical Investigation
|
March 17, 2025
Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures
Chester J Kao, Soren Charmsaz, Stephanie L Alden, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 131) with videos related to
Sort By:
Page
of 14
Oncoimmunology
|
August 15, 2025
A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages
Katherine M Bever, Sarah M Shin, Jennifer N Durham, et al.
Cell Metabolism
|
November 19, 2019
Selective Persulfide Detection Reveals Evolutionarily Conserved Antiaging Effects of S-Sulfhydration
Jasmina Zivanovic, Emilia Kouroussis, Joshua B Kohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer
Thatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
Biorxiv : the Preprint Server for Biology
|
October 31, 2023
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade
Daniel H Shu, Won Jin Ho, Luciane T Kagohara, et al.
Iscience
|
January 15, 2025
CD137 agonism enhances anti-PD1 induced activation of expanded CD8<sup>+</sup> T cell clones in a neoadjuvant pancreatic cancer clinical trial
Janelle M Montagne, Jacob T Mitchell, Joseph A Tandurella, et al.
Nature Communications
|
February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial
Amanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Nature Communications
|
April 15, 2026
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial
Amanda L Huff, S Daniel Haldar, Alexander A Girgis, et al.
The Journal of Trauma and Acute Care Surgery
|
April 4, 2023
Moving the needle on time to resuscitation: An EAST prospective multicenter study of vascular access in hypotensive injured patients using trauma video review
Ryan P Dumas, Michael A Vella, Amelia W Maiga, et al.
Nature Immunology
|
October 25, 2024
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma
Daniel H Shu, Won Jin Ho, Luciane T Kagohara, et al.
The Journal of Clinical Investigation
|
March 17, 2025
Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures
Chester J Kao, Soren Charmsaz, Stephanie L Alden, et al.
Page
of 14